Sales rise 9.01% to Rs 3.51 crore
Net profit of Beryl Drugs declined 74.07% to Rs 0.14 crore in the quarter ended September 2018 as against Rs 0.54 crore during the previous quarter ended September 2017. Sales rose 9.01% to Rs 3.51 crore in the quarter ended September 2018 as against Rs 3.22 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales3.513.22 9 OPM %9.977.45 -PBDT0.290.21 38 PBT0.250.11 127 NP0.140.54 -74Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content